CA2234936A1 - Composition pour traiter une affection intestinale inflammatoire par l'administration de n-acetylglucosamine par le colon et traitement connexe - Google Patents

Composition pour traiter une affection intestinale inflammatoire par l'administration de n-acetylglucosamine par le colon et traitement connexe Download PDF

Info

Publication number
CA2234936A1
CA2234936A1 CA002234936A CA2234936A CA2234936A1 CA 2234936 A1 CA2234936 A1 CA 2234936A1 CA 002234936 A CA002234936 A CA 002234936A CA 2234936 A CA2234936 A CA 2234936A CA 2234936 A1 CA2234936 A1 CA 2234936A1
Authority
CA
Canada
Prior art keywords
composition
bowel disease
inflammatory bowel
ibd
acetylglucosamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002234936A
Other languages
English (en)
Other versions
CA2234936C (fr
Inventor
Simon Murch
Ian W. French
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GLUCOGENICS PHARMACEUTICALS Inc
Original Assignee
GLUCOGENICS PHARMACEUTICALS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GLUCOGENICS PHARMACEUTICALS Inc filed Critical GLUCOGENICS PHARMACEUTICALS Inc
Priority to CA002234936A priority Critical patent/CA2234936C/fr
Priority to US09/261,194 priority patent/US6046179A/en
Priority to HU0101514A priority patent/HUP0101514A3/hu
Priority to CZ20003846A priority patent/CZ20003846A3/cs
Priority to IL13907299A priority patent/IL139072A0/xx
Priority to AU27092/99A priority patent/AU2709299A/en
Priority to EP99907220A priority patent/EP1071432A1/fr
Priority to JP2000544333A priority patent/JP2002512195A/ja
Priority to PL99343634A priority patent/PL343634A1/xx
Priority to PCT/CA1999/000218 priority patent/WO1999053929A1/fr
Publication of CA2234936A1 publication Critical patent/CA2234936A1/fr
Priority to NO20005223A priority patent/NO20005223L/no
Application granted granted Critical
Publication of CA2234936C publication Critical patent/CA2234936C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
CA002234936A 1998-04-17 1998-04-17 Composition pour traiter une affection intestinale inflammatoire par l'administration de n-acetylglucosamine par le colon et traitement connexe Expired - Fee Related CA2234936C (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CA002234936A CA2234936C (fr) 1998-04-17 1998-04-17 Composition pour traiter une affection intestinale inflammatoire par l'administration de n-acetylglucosamine par le colon et traitement connexe
US09/261,194 US6046179A (en) 1998-04-17 1999-03-03 Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine
PCT/CA1999/000218 WO1999053929A1 (fr) 1998-04-17 1999-03-12 Composition et methode permettant de traiter les affections inflammatoires de l'intestin par administration intra-colique de n-acetylglucosamine
IL13907299A IL139072A0 (en) 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
AU27092/99A AU2709299A (en) 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
EP99907220A EP1071432A1 (fr) 1998-04-17 1999-03-12 Composition et methode permettant de traiter les affections inflammatoires de l'intestin par administration intra-colique de n-acetylglucosamine
HU0101514A HUP0101514A3 (en) 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
PL99343634A PL343634A1 (en) 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
CZ20003846A CZ20003846A3 (cs) 1998-04-17 1999-03-12 Kompozice pro léčbu zánětlivého onemocnění střev dávkováním N-acetylglukosaminu do tlustého střeva
JP2000544333A JP2002512195A (ja) 1998-04-17 1999-03-12 Ｎ−アセチルグルコサミンの結腸投与による炎症性腸疾患用の組成物およびその治療
NO20005223A NO20005223L (no) 1998-04-17 2000-10-17 Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002234936A CA2234936C (fr) 1998-04-17 1998-04-17 Composition pour traiter une affection intestinale inflammatoire par l'administration de n-acetylglucosamine par le colon et traitement connexe

Publications (2)

Publication Number Publication Date
CA2234936A1 true CA2234936A1 (fr) 1999-10-17
CA2234936C CA2234936C (fr) 2004-06-29

Family

ID=4162337

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002234936A Expired - Fee Related CA2234936C (fr) 1998-04-17 1998-04-17 Composition pour traiter une affection intestinale inflammatoire par l'administration de n-acetylglucosamine par le colon et traitement connexe

Country Status (8)

Country Link
EP (1) EP1071432A1 (fr)
JP (1) JP2002512195A (fr)
CA (1) CA2234936C (fr)
CZ (1) CZ20003846A3 (fr)
HU (1) HUP0101514A3 (fr)
IL (1) IL139072A0 (fr)
NO (1) NO20005223L (fr)
PL (1) PL343634A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008103345A2 (fr) 2007-02-19 2008-08-28 Marine Polymer Technologies, Inc. Compositions hémostatiques et régimes thérapeutiques
KR101098581B1 (ko) * 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
NZ703163A (en) 2010-04-15 2016-06-24 Marinepolymer Tech Inc Anti-bacterial applications of poly-n-acetylglucosamine nanofibers
CA2832859C (fr) * 2011-04-15 2020-06-16 Marine Polymer Technologies, Inc. Traitement de maladies avec des nanofibres de poly-n-acetylglucosamine
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (fr) * 2013-03-15 2014-09-18 Aihol Corporation Formulation pharmaceutique contenant un glycosaminoglycane
US10111838B2 (en) * 2014-11-26 2018-10-30 Evonik Roehm Gmbh Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

Also Published As

Publication number Publication date
JP2002512195A (ja) 2002-04-23
NO20005223D0 (no) 2000-10-17
PL343634A1 (en) 2001-08-27
EP1071432A1 (fr) 2001-01-31
CA2234936C (fr) 2004-06-29
HUP0101514A2 (hu) 2001-11-28
HUP0101514A3 (en) 2003-07-28
NO20005223L (no) 2000-11-20
CZ20003846A3 (cs) 2002-03-13
IL139072A0 (en) 2001-11-25

Similar Documents

Publication Publication Date Title
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
MY131810A (en) Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
EP1283054A4 (fr) Medicaments permettant de traiter les complications du diabete et des neuropathies et utilisation de ces medicaments
PT1409006E (pt) Misturas monodispersas e métodos de tratamento de diabetes
HRP920632B1 (en) Oral composition for the treatment of inflammatory bowel deseases
EP2767291A3 (fr) Traitement d'une glycogénose de type II
CA2289717A1 (fr) Nouveau traitement de la constipation
EP1014996A4 (fr) Compositions de saccharide et methodes de traitement specifiques de la maladie d'alzheimer et d'autres amyloidoses
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
WO1999064059A3 (fr) Utilisation de la secretine pour le traitement de l'autisme et d'autres troubles du comportement, troubles neurologiques ou immunologiques
NO954996L (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
MY137348A (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same
IL133585A0 (en) Soluble prodrugs of paclitaxel
WO2001030802A3 (fr) Traitements therapeutiques pour des deficiences en cellules sanguines
CA2311356A1 (fr) Procede pour le traitement de la maladie d'alzheimer
CA2150184A1 (fr) Composition pharmaceutique pour le traitement des affections intestinales inflammatoires
EP1251126A3 (fr) Derives de benzenesulfonyle a substitution fluor pour le traitment d'inflammation
WO2001017517A3 (fr) Utilisation des metabolites de l'acide $g(a)-linolenique pour le traitement et la prevention du cancer
WO2000018316A3 (fr) Composition ophtalmique agreable, a liberation prolongee, et procede de therapie oculaire
CA2290482A1 (fr) Composition contenant du fructosane pour la prevention et le traitement du cancer du colon et procede preventif et therapeutique du cancer du colon
CA2234936A1 (fr) Composition pour traiter une affection intestinale inflammatoire par l'administration de n-acetylglucosamine par le colon et traitement connexe
CA2150183A1 (fr) Composition pharmaceutique pour le traitement des affections hemoroidales
WO2003049667A3 (fr) Methode de traitement du cancer
AU2003290015A1 (en) Mastitis treatment

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130417